| CHECK-CAP LTD IS 48 |
| Israel |
| Gesundheit |
| IL0011336851 / A14QUF |
| 7CC (Frankfurt) / MBAI (NASDAQ) |
| FRA:7CC, ETR:7CC, 7CC:GR, NASDAQ:MBAI |
| - |
| https://mbody.ai/ |
|
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Israel, specializing in the development of innovative capsule-based screening technology for colorectal cancer detection. Founded in 2004, the company focuses on its proprietary ..
>Volltext.. |
| 10.73 Mio. EUR |
| 10.56 Mio. EUR |
| - |
| -2.05 Mio. EUR |
| 3.58 Mio. EUR |
| 0.64 EUR |
| 0.01 Mio. EUR |
| 0.19 Mio. EUR |
| -0.04 Mio. EUR |
| 0.05 |
| - |
| - |
| - |
| - |
| - |
| - |
| CHECK-CAP, CHECK CAP, MBODY AI |
| 13.08.26 |
|